Narhex Life Sciences

Follow
Follow Organisations, People and Lists Stay on top of the latest updates for your desired data.

Industry Lists

Former Companies
The former Company Narhex Life Sciences Limited, through its 50% interest in Narhex Life Sciences International Limited, engaged in the research, development, and commercialization of drugs for the treatment of HIV/AIDS primarily in Australia. It focused on developing and commercializing its anti-HIV protease inhibitor DG-17. DG-17 is the water-soluble pro-drug of the active anti-HIV drug DG-35. The Company ceased trading in July 2015, following a reverse takeover by ResApp.

Contact Details

,

Article Timeline

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options